Learn how AsiDNA™ by Onxeo_Onco fights #tumor persistent #cells that play a key role in resistance to targeted therapies and #cancer relapse Watch the video 👉 vimeo.com/510726559 © Hanson Wade 2021 – posted with permission

#Onxeo is committed to women's health in the treatment of women's cancers. #Revocan #Cancer #Oncology #8M2021 #WomensDay2021

#Onxeo launches a €9.3 million rights issue For more information 👉 onxeo.com

Pour la semaine nationale de lutte contre le #cancer, nous vous présentons Onxeo_Onco ➡️ une #biotech qui conçoit et développe de nouveaux #médicaments contre le cancer en ciblant les fonctions de réparation de l'ADN des #tumeurs. Plus d'infos 👉 onxeo.com/fr

[INTERVIEW] Retrouvez Judith Greciet, Directrice Générale d'Onxeo_Onco, qui commente les récents développements d’#Onxeo et explique les raisons de l'augmentation de capital en cours ➡️ vimeo.com/527329740 #Interview #Onxeo

Judith Greciet, Directrice Générale d'Onxeo_Onco répond à une question concernant l'augmentation de capital en cours 👇

Judith Greciet, Directrice Générale d'Onxeo_Onco détaille les prochaines étapes majeures d'#Onxeo 👇

Retrouvez l'#interview de Judith Greciet, Directrice Générale d'Onxeo_Onco chez B SMART 4Change concernant la levée de fonds d'#Onxeo 👇 bsmart.fr/video/4854-sma… #BSmart #SmartBourse #finance #bourse

#Onxeo to Present New Preclinical Data at AACR (American Association for Cancer Research) 2021 👉 onxeo.com/onxeo-to-prese…

#Onxeo announces the #success of its Rights Issue with €9.7 million raised !

#Onxeo Reports FYR 2020 and Provides Business Update: financial visibility until end-2022, enabling the expansion of clinical and industrial development of #AsiDNA™

#Onxeo Receives Notice of Allowance for a New Patent Broadening the Protection of AsiDNA™ in combination with a PARP Inhibitor in the United States until 2036 More informations 👉 bit.ly/3zhYlLV

#Onxeo is pleased to announce its attendance at the Kepler Cheuvreux Digital Life Science Days

#Onxeo Appoints Dr. Shefali Agarwal as Chairwoman of the Board ! More information here 👉 bit.ly/37bnWcF

#Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector More information 👉 bit.ly/3DJGorb

AsiDNA™’s pioneering data highlighted at the EACR-AstraZeneca Virtual Conference during two dedicated sessions Click here for more infos 👉 bit.ly/3rJpaaJ #ONXEO #eacrAstraZeneca AstraZeneca

We participate in the DDR, ATR & PARP Inhibitors Summit 2022 ! Wael Jdey, Lead Scientist at #ONXEO will present today at 8AM EST and at 9:30AM EST Click here for more info 👉 ddr-inhibitors-summit.com #event #digitalevent #PARPinhibitors #Resistance

At #Onxeo, #clinical-stage #biotechnology company developing innovative #oncology drugs targeting #tumor DNA Damage Response, we support the #WorldCancerDay onxeo.com

Onxeo $ALONX appoints Dr. Shefali Agarwal as President and Chief Executive Officer More information here👉bit.ly/3jixEjq

New preclinical data confirming AsiDNA™’s abilities to protect from #anticancer treatment toxicity and fight #tumor resistance presented during poster and oral sessions at the American Association for Cancer Research Annual Meeting (#AACR) More info: bit.ly/3O5PzIj